|
|
|
|
LEADER |
05451nam a2200385 a 4500 |
001 |
67ffe049-318f-4c53-902d-8f00715a4f0c |
005 |
20230729000000.0 |
008 |
190816s2020||||nyu|||||s|||||||||||eng|| |
020 |
|
|
|a 9781260455281 (print-ISBN)
|
020 |
|
|
|a 1260455289 (print-ISBN)
|
035 |
|
|
|a (OCoLC)1111696184
|
050 |
|
4 |
|a RC55
|
060 |
1 |
0 |
|a WB 141
|
082 |
0 |
4 |
|a 616.075
|2 23
|
245 |
0 |
0 |
|a Current Medical Diagnosis and Treatment 2020
|h [electronic resource] /
|c Edited by Maxine A. Papadakis, Stephen J. McPhee, Michael W. Rabow.
|
260 |
|
|
|a New York, N.Y. :
|b McGraw-Hill Education LLC.,
|c c2020.
|
300 |
|
|
|a 1 online resource (xv, 1936 pages.) :
|b ill., figs., tables;
|c 26 cm.
|
490 |
1 |
|
|a McGraw-Hill's AccessMedicine
|
490 |
1 |
|
|a Lange medical book
|
500 |
|
|
|a "A Lange medical book."
|
505 |
0 |
|
|a Part e1: Anti-Infective Chemotherapeutic & Antibiotic Agents -- e1-01: Penicillins -- e1-02: Cephalosporins -- e1-03: Other Beta-Lactam Medications -- e1-04: Erythromycin Group (Macrolides) -- e1-05: Ketolides -- e1-06: Tetracycline Group -- e1-07: Tetracycline Derivatives -- e1-08: Chloramphenicol -- e1-09: Aminoglycosides -- e1-10: Polymyxins -- e1-11: Antituberculous Medications -- e1-12: Alternative Medications in Tuberculosis Treatment -- e1-13: Rifamycins -- e1-14: Sulfonamides & Antifolate Medications -- e1-15: Sulfones -- e1-16: Specialized Medications Used Against Bacteria: Bacitracin, Mupirocin, Clindamycin, Metronidazole & Tinidazole, Vancomycin, Bezlotoxumab -- e1-17: Streptogramins -- e1-18: Oxazolidinediones -- e1-19: Daptomycin -- e1-20: Telavancin, Dalbavancin, Oritavancin -- e1-21: Quinolones -- e1-22: Pentamidine & Atovaquone -- e1-23: Urinary Antiseptics -- e1-24: Antifungal Medications -- e1-25: Antiviral Chemotherapy -- Part e2: Diagnostic Testing & Medical Decision Making -- e2-01: Overview: Diagnostic Testing & Medical Decision Making -- e2-02: Benefits, Risks, & Costs of Diagnostic Tests -- e2-03: Diagnostic Test Preparation -- e2-04: Diagnostic Test Characteristics -- e2-05: Use of Tests in Diagnosis & Management -- e2-06: Likelihood Ratios & Odds-Probability Conversion in Medical Decision-Making -- Part e3: Information Technology in Patient Care -- e3-01: Overview: Information Technology in Patient Care -- e3-02: Patient Confidentiality & Information Technology -- e3-03: Clinical Uses of E-Mail -- e3-04: Electronic Health Records -- e3-05: Computerized Provider Order Entry -- e3-06: Clinical Decision Support -- e3-07: Social Media & Websites in Clinical Practice -- e3-08: Mobile Computing for Clinicians -- e3-09: Telemedicine -- Part e4: Integrative Medicine -- e4-01: Overview: Integrative Medicine -- e4-02: Herbal & Dietary Supplements -- e4-03: Botanical Medicines -- e4-04: Non-Botanical Dietary Supplements -- e4-05: Acupuncture -- e4-06: Mind-Body Medicine -- e4-07: Meditation -- e4-08: Guided Imagery -- e4-09: Biofeedback -- e4-10: Hypnosis -- e4-11: Yoga -- e4-12: Tai Chi -- Part e5: Podiatric Disorders -- e5-01: Bunion -- e5-02: Hammertoe -- e5-03: Hallux Limitus -- e5-04: Fifth Metatarsal Fracture -- e5-05: Morton Neuroma -- e5-06: Onychocryptosis (Ingrown Nail) -- e5-07: Achilles Tendonitis -- e5-08: Plantar Fasciitis -- e5-09: Plantar Plate Injuries (Predislocation Syndrome) -- e5-10: Flatfoot (Pes Planus) -- Part e6: Women's Health Issues -- e6-01: Overview: Women's Health Issues -- e6-02: Preventive Health Care in Women -- e6-03: Cardiovascular Disease Prevention in Women -- e6-04: Cancer Prevention in Women -- e6-05: Osteoporosis Prevention in Women -- e6-06: Prevention of Sexually Transmitted Infections in Women -- e6-07: Depression Screening in Women -- e6-08: Intimate Partner Violence Issues for Women -- e6-09: Eating Disorders in Women -- e6-10: Sexuality & Sexual Health in Women -- e6-11: Low Sexual Desire Disorder in Women -- e6-12: Chronic Pelvic Pain in Women -- e6-13: Mastalgia -- e6-14: The Palpable Breast Mass -- e6-15: Asymptomatic Ovarian Masses -- e6-16: Female Pattern Hair Loss -- Part e7: Appendix: Therapeutic Drug Monitoring & Laboratory Reference Intervals, & Pharmacogenetic Testing -- e7-01: Therapeutic Drug Monitoring -- e7-02: Reference Intervals for Commonly Used Tests -- e7-03: Selected Pharmacogenetic Tests: Clinical Relevance -- e7-04: Commonly Used Blood Specimen Collection Tubes.
|
530 |
|
|
|a Also issued in online and PDF version.
|
546 |
|
|
|a In English.
|
588 |
|
|
|a Description based on cover image and table of contents, viewed on Aug. 16, 2019.
|
650 |
|
0 |
|a Diagnosis.
|
650 |
|
0 |
|a Therapeutics.
|9 33289
|
650 |
|
0 |
|a Medicine.
|
700 |
1 |
|
|a Papadakis, Maxine A.,
|e editor.
|9 163797
|
700 |
1 |
|
|a McPhee, Stephen J.,
|e editor.
|9 163798
|
700 |
1 |
|
|a Rabow, Michael W.,
|e editor.
|9 748793
|
776 |
0 |
8 |
|i Print version:
|t Current Medical Diagnosis and Treatment 2020.
|d New York, N.Y. : McGraw-Hill Education LLC.,
|c 2020.
|
830 |
|
0 |
|a McGraw-Hill's AccessMedicine.
|9 159672
|
830 |
|
0 |
|a Lange medical book.
|9 159673
|
999 |
1 |
0 |
|i 67ffe049-318f-4c53-902d-8f00715a4f0c
|l 2751446
|s US-PAGLAUL
|m current_medical_diagnosis_and_treatment_2020__________________________elect20201936___mcgraa___________________________________________________________________________e
|
999 |
1 |
0 |
|i 67ffe049-318f-4c53-902d-8f00715a4f0c
|l 678773
|s US-PERMC
|m current_medical_diagnosis_and_treatment_2020__________________________elect20201936___mcgraa___________________________________________________________________________e
|